| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
Laboratoire d'Ophtalmologie, Hôtel Dieu, Université Paris-France.
Address correspondence to Leslie Robert, Laboratoire d'Ophtalmologie, Hôtel Dieu, Université Paris 5, 1 place du parvis Notre Dame, 75181 Paris cedex 04, France. E-mail: lrobert5{at}wanadoo.fr
This is a contribution to the debate raised by the position statement on aging ( 1) and comments ( 2) concerning the rapid increase of anti-aging medicine. After a short summary of the history of social attitude to aging and the emergence of experimental gerontology, the French situation is described, emphasizing the economic basis of this phenomenon: increasing insurance fees and tightly controlled honoraria push an increasing number of physicians to this new discipline. No lack of communication seems to be involved between basic gerontologists and physicians ( 2). Anti-aging medicine profits of the increasing population of seniors who want to remain healthy, look young and dislike to consult geriatricians. And also of the fact that no over-the-counter delivery of drugs is available in France. For these reasons there is no serious hope to stop it otherwise than by state legislation.
This article has been cited by other articles:
![]() |
G. E. Alkema and D. E. Alley Gerontology's Future: An Integrative Model for Disciplinary Advancement. Gerontologist, October 1, 2006; 46(5): 574 - 582. [Abstract] [Full Text] [PDF] |
||||
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|